Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
-14.44%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$6.68B
AUM Growth
-$2.22B
(-25%)
Cap. Flow
-$1.02B
Cap. Flow
% of AUM
-15.28%
Top 10 Holdings %
Top 10 Hldgs %
17.31%
Holding
522
New
139
Increased
61
Reduced
97
Closed
190
Top Buys
| 1 |
Cognizant
CTSH
|
$131M |
| 2 |
Lennar Class A
LEN
|
$99M |
| 3 |
RHT
Red Hat Inc
RHT
|
$79M |
| 4 |
Skyworks Solutions
SWKS
|
$69M |
| 5 |
Procter & Gamble
PG
|
$68.4M |
Top Sells
| 1 |
Electronic Arts
EA
|
$174M |
| 2 |
COL
Rockwell Collins
COL
|
$139M |
| 3 |
AET
Aetna Inc
AET
|
$137M |
| 4 |
Broadcom
AVGO
|
$105M |
| 5 |
CA
CA, Inc.
CA
|
$99M |
Sector Composition
| 1 | Technology | 26.24% |
| 2 | Industrials | 13.77% |
| 3 | Healthcare | 11.91% |
| 4 | Consumer Discretionary | 11.12% |
| 5 | Financials | 11.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTGM
276
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $1.24M | 0.02% |
+2,711
| New | +$1.24M |
|
277
Qfin Holdings, Inc. American Depositary Shares
QFIN
$3.81B
| $1.24M | 0.02% |
+79,830
| New | +$1.24M |
|
|
CNCE
278
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.19M | 0.02% |
+95,000
| New | +$1.19M |
|
279
MeiraGTx Holdings
MGTX
$619M
| $1.19M | 0.02% |
123,000
-27,000
| -18% | -$260K |
|
280
Timken Company
TKR
$5.42B
| $1.18M | 0.02% |
+31,679
| New | +$1.18M |
|
281
AerCap
AER
$22B
| $1.05M | 0.02% |
26,617
-461,756
| -95% | -$18.3M |
|
282
US Foods
USFD
$17.5B
| $1.04M | 0.02% |
+32,955
| New | +$1.04M |
|
283
McDonald's
MCD
$224B
| $953K | 0.01% |
+5,368
| New | +$953K |
|
284
BorgWarner
BWA
$9.53B
| $894K | 0.01% |
29,224
-255,533
| -90% | -$7.82M |
|
285
Parker-Hannifin
PH
$96.1B
| $831K | 0.01% |
+5,569
| New | +$831K |
|
286
KALA BIO
KALA
$102M
| $768K | 0.01% |
+3,143
| New | +$768K |
|
287
Deere & Co
DE
$128B
| $710K | 0.01% |
+4,758
| New | +$710K |
|
288
scPharmaceuticals
SCPH
$299M
| $666K | 0.01% |
177,135
-53,684
| -23% | -$202K |
|
289
CVS Health
CVS
$93.6B
| $655K | 0.01% |
+10,000
| New | +$655K |
|
290
XPO
XPO
$15.4B
| $630K | 0.01% |
31,938
-61,179
| -66% | -$1.21M |
|
291
Alaska Air
ALK
$7.28B
| $602K | 0.01% |
9,895
-110,525
| -92% | -$6.72M |
|
|
PHAS
292
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $592K | 0.01% |
+191,602
| New | +$592K |
|
|
TCDA
293
DELISTED
Tricida, Inc. Common Stock
TCDA
| $590K | 0.01% |
25,000
| – | – |
|
|
HZNP
294
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $581K | 0.01% |
+29,719
| New | +$581K |
|
|
XENT
295
DELISTED
Intersect ENT, Inc
XENT
| $574K | 0.01% |
+20,386
| New | +$574K |
|
296
TopBuild
BLD
$12.3B
| $543K | 0.01% |
12,072
-5,870
| -33% | -$264K |
|
297
Hershey
HSY
$37.6B
| $523K | 0.01% |
+4,880
| New | +$523K |
|
|
VSLR
298
DELISTED
VIVINT SOLAR, INC.
VSLR
| $472K | 0.01% |
+123,878
| New | +$472K |
|
299
Sutro Biopharma
STRO
$89.9M
| $451K | 0.01% |
50,000
-50,000
| -50% | -$451K |
|
300
General Mills
GIS
$27B
| $417K | 0.01% |
+10,711
| New | +$417K |
|